After the UK and Bahrain gave permission to use the Pfizer company’s Corona vaccine, the company has now sought permission to launch it in India as well.
The company’s Indian arm Pfizer India has sought permission from the Controller General of Drugs of India (DCGI) to launch its Covid-19 vaccine in the country under the Emergency Use Authority (EUA). With this, Pfizer India has become the first company to file an application with DCGI for the Covid-19 vaccine.
In its application submitted to the drug regulator on December 4, the company has sought permission to import Covid-19 (Corona virus) vaccine for sale and distribution in the country. Apart from this, under the special provisions of the new Drugs and Medical Trials Rules-2019, it has also been requested to exempt the mandatory from clinical trials on Indian population.
According to a source, the company has sought permission to import and sell Pfizer-BioNotech’s Covid-19 mRNA vaccine BNT 162B2 in the country in an EUA application filed on the CT-18 form. The UK approved the vaccine on Wednesday.
Along with this, the vaccine had claimed 95 percent success. But the obligation to keep the temperature at minus 70 degrees Celsius has been raising doubts about the success of Pfizer’s vaccine in India. In such a situation, it will be a big challenge for the company to arrange the vaccine after landing here.